IL6 and Peritoneal Fibrosis: In this study, we first assessed the effect of TA on the IL-6-induced change of the phenotype and the mobility of HPMCs and further investigated the signaling regulatory mechanism, in order to provide evidence for future clinical trials in the field of peritoneal fibrosis.